Delayed 18F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients

被引:0
|
作者
Ma, SY
See, LC
Lai, CH
Chou, HH
Tsai, CS
Ng, KK
Hsueh, S
Lin, WJ
Chen, JT
Yen, TC
机构
[1] Chang Gung Mem Hosp, Dept Nucl Med, Taipei 105, Taiwan
[2] Chang Gung Univ, Biostat Consulting Ctr, Dept Publ Hlth, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, Taipei 105, Taiwan
[4] Chang Gung Mem Hosp, Dept Radiat Oncol, Taipei 105, Taiwan
[5] Chang Gung Mem Hosp, Dept Radiol, Taipei 105, Taiwan
[6] Chang Gung Mem Hosp, Dept Pathol, Taipei 105, Taiwan
[7] Inst Nucl Energy Res, Taoyuan, Taiwan
关键词
delayed F-18-FDG PET; paraaortic lymph nodes; cervical cancer;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
This prospective study investigated the usefulness of dual-phase F-18-FDG PET scans (40 min and 3 h) in detecting paraaortic lymph node (PALN) metastasis for cervical cancer. Methods: One hundred four consecutive cervical cancer patients (international Federation of Gynecology and Obstetrics staging Ib-IVb, recurrent or persistent tumors) were included. All patients received a whole-body F-18-FDG PET scan at 40 min and an additional scan from the T11 level to the inguinal region at 3 h after injection of 370 MBq F-18-FDG. The maximum standardized uptake value (SUV) and retention index (RI [%], obtained by subtracting the normalized SUV value obtained at 40 min from that at 3 h) of the lesions were determined. Results: In all, 38 of the 104 patients were confirmed to have PALN metastases. For 31 patients (81.6%) with 13 upper (L1-L2 level) and 30 lower (L3-L4 level) PALNs, these metastases were detected with the 40-min scan. In addition, for 7 patients (18.4%) with 7 lower PALNs, metastases were found with the 3-h scan (RI = 12.6%). Two patients (3.0%) had 2 false-positive lesions initially (40 min) but were classified as benign with the 3-h scan. The sensitivity, specificity, and accuracy of 18F-FDG PET scans at 40 min were 81.6%, 97.0%, and 91.3%, respectively. These quantities were all 100% when both the 40-min and 3-h scans were taken together. Eight patients (21.1 %) had their treatment planning changed. We divided the 38 patients into 2 subgroups. Subgroup A included those with either only upper or only lower PALN metastases, and subgroup B included those with both upper and lower PALN metastases. In subgroup A, the SUV values were greater in the upper than in the lower PALNs in both the 40-min and 3-h images (P = 0.077). In subgroup B, there was no significant difference of SUV values between upper and lower PALNs in the 40-min (P = 0.433) and 3-h (P = 0.937) images. Conclusion: Our results showed that an additional 3-h scan is helpful for PALN detection of cervical cancer patients. A delayed image (3 h) is especially useful for lower PALN metastases.
引用
收藏
页码:1775 / 1783
页数:9
相关论文
共 50 条
  • [41] Diagnostic Performance of 18F-FDG PET/CT for Lymph Node Staging in Penile Cancer
    Lee, Sang Woo
    Kim, Seong-Jang
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (05) : 402 - 408
  • [42] Added value of combined 18F-FDG PET/CT for detection of osseous metastases in cancer patients
    Ali, Susan Adil
    Abd Elkhalek, Yasser Ibrahim
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2016, 47 (02): : 453 - 458
  • [43] Lymph Node Assessment with 18F-FDG-PET and MRI in Uterine Cervical Cancer
    Monteil, Jacques
    Maubon, Antoine
    Leobon, Sophie
    Roux, Sonia
    Marin, Benoit
    Renaudie, Joel
    Genet, Dominique
    Fermeaux, Veronique
    Aubard, Yves
    Tubiana-Mathieu, Nicole
    ANTICANCER RESEARCH, 2011, 31 (11) : 3865 - 3871
  • [44] Early and delayed prediction of axillary lymph node neoadjuvant response by 18F-FDG PET/CT in patients with locally advanced breast cancer
    Ana María García Vicente
    Ángel Soriano Castrejón
    Alberto León Martín
    Fernanda Relea Calatayud
    María del Mar Muñoz Sánchez
    Miguel Ángel Cruz Mora
    Germán Andrés Jiménez Londoño
    Ruth Espinosa Aunión
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 1309 - 1318
  • [45] Early and delayed prediction of axillary lymph node neoadjuvant response by 18F-FDG PET/CT in patients with locally advanced breast cancer
    Garcia Vicente, Ana Maria
    Soriano Castrejon, Angel
    Leon Martin, Alberto
    Relea Calatayud, Fernanda
    Munoz Sanchez, Maria del Mar
    Cruz Mora, Miguel Angel
    Jimenez Londono, German Andres
    Espinosa Aunion, Ruth
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (07) : 1309 - 1318
  • [46] The role of CT, MR, US, and 18F-FDG PET/CT in detection of upper cervical lymph node metastases in oral cavity squamous cell carcinoma
    Chu, H. R.
    Kim, J. H.
    Oh, S. J.
    Ahn, H. Y.
    Yoon, D. Y.
    Rho, Y. S.
    ORAL ONCOLOGY, 2009, : 84 - 85
  • [47] The maxSUV in tumor and lymph node by 18F-FDG PET/CT as prognostic value in patients with node positive breast cancer
    Kang, S. H.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S139 - S139
  • [48] Diagnostic accuracy of ultrasound, 18F-FDG-PET/CT, and fused 18F-FDG-PET-MR images with DWI for the detection of cervical lymph node metastases of HNSCC
    Philipp Heusch
    Christoph Sproll
    Christian Buchbender
    Elena Rieser
    Jan Terjung
    Christina Antke
    Inga Boeck
    Stephan Macht
    Axel Scherer
    Gerald Antoch
    Till A. Heusner
    Jörg Handschel
    Clinical Oral Investigations, 2014, 18 : 969 - 978
  • [49] Diagnostic accuracy of ultrasound, 18F-FDG-PET/CT, and fused 18F-FDG-PET-MR images with DWI for the detection of cervical lymph node metastases of HNSCC
    Heusch, Philipp
    Sproll, Christoph
    Buchbender, Christian
    Rieser, Elena
    Terjung, Jan
    Antke, Christina
    Boeck, Inga
    Macht, Stephan
    Scherer, Axel
    Antoch, Gerald
    Heusner, Till A.
    Handschel, Joerg
    CLINICAL ORAL INVESTIGATIONS, 2014, 18 (03) : 969 - 978
  • [50] COMPARISON OF MRI AND 18F-FDG PET/CT IN DETECTION OF REGIONAL LYMPH NODE METASTASIS IN VULVAR CANCER AND VAGINAL CANCER
    Christiansen, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1609 - 1609